Doubling? #CureVac #CVAC @curevacrna #vaccineI think there is a potential for doubling.
Greetings from Hanover, Germany
Stefan Bode
CVAC trade ideas
$CVAC - curling back up - Short term target 124$CVAC - curling back up - Short term target 124!
124 breaks and holds and see some consolidation to see a bigger move towards 170+
CVAC - Downtrend broken ?It has left the downtrend today. The Biden/DC victories and the news about a cooperation with Bayer have helped a lot.
$CVAC Curevac Bullish Reversal Targets
German Vaccine Developer CVAC has suffered a horrid decline in December
following a Parabolic move higher.
Tuesdays sessions seen the stock find support on 3 key support.
1) Fibonacci Golden pocket
2) 50MA
3)Previous Breakout level.
We will not look with several targets in mind.
$93.60 & $100 Gap fill levels
$105.33 A previous breakout level.
This is a very volatile and news driven stock so trade with care.
nice reverse on CVACI was calling short term oversold, it turned around nicely today, I averaged down at bottom and now i sit around zero profit, should continue stepping up slowly, all the way to ~106-110 in the coming days up to mid Jan. Any comments?
CVAC to 220CVAC is breaking the support @ 85 today and may be heading to fill the gap @ 61.94.
60’s may prove to be the next support.
After that it should be taking another wave up to 220’s.
short term buy opportunity on CVACJust opened up small long position on CVAC, its oversold now and has some potential to go to next volume level. Any comments?
BREAKOUT TIGHT BASE AND HIGH VOLUM BUY CVAC ABOUT 108$CureVac Announces Financial Results and Business Updates for the Third Quarter and First Nine Months of 2020
Operating result
Operating loss was €36.8 million and €63.2 million for the three and nine months ended September 30, 2020, respectively, representing an increase of €17.6 million and a decrease of €1.2 million, or an increase of 92% and a decrease of 2%, from -€19.2 million and -€64.4 million for the same periods in 2019, respectively.
COVID-19 prophylactic vaccine candidate: CVnCoV on track for advanced clinical testing
Interim Phase 1 data showed generally good tolerability for CVnCoV and strong antibody responses in addition to first indication of T cell activation
Stability confirmed for at least three months at standard refrigerator temperature and for up to 24 hours at room temperature
Pivotal Phase 2b/3 to be initiated shortly with 12µg dose
Agreement with European Commission to supply 225 million doses of CVnCoV and an option for an additional 180 million doses
Building a strong European manufacturing network to supply up to 300 million doses by end of 2021 and up to 600 million doses by the end of 2022
Phase 1 results for oncology lead candidate, CV8102, confirm tolerability and responses in additional cancer indication
Financials: Cash position of €892 million as of September 30, 2020
1 % CAPITAL
$CVAC Curevac NV $100 key Level
The European vaccine candidates continues to rally and $100 is the next key target for the bulls.
7MA providing strong support.
$CVAC Curevac Nv Reversal to $85.00 😷😷💉💉
CVAC may be back on the buy list- the recent pullback
has now found support from the rising 7ma.
The RSI has worked off overbought conditions.
Possible move back to $85.00 in the short term.
Obviously this stock is subject to COVID news and
needs to be traded with care and reality.
Positive data from the company and we see the 3rd wave target at $121
CVAC Short OpportunityNASDAQ:CVAC
Possible Scenario: SHORT
Evidence: Double TOP
It's just my opinion and could be 100% wrong
$CVAC Curevac heading for the $80's
CVAC looks to be attracting investor attentions at long last, volume is increasing
as their Vaccine commentary becomes increasingly bullish.
Currently forming sub-wave 2 of the the primary wave2.
Near term targets $82.00 - $85.00 - $87.00
$CVAC $70.00 short term target for European Covid play Curevac
Now up over 30% from the trendline break and surpassed previous targets.
Next targets which could very well be hit today is $69-$70. where the
Fibonacci golden pocket and horizontal resistance may stall the march higher..
$CVAC Curevac On Alert for move above $59
CVAC begins to look increasingly bullish having broke above the downtrend.
Volume does remain low though.
Bullish moving average cross imminent
Indicators in bullish trajectory.
Potential entry above $59.00 at Fibonacci resistance.
Target $64-$66
$CVAC Curevac - Under the Radar Covid Stock
CVAC has staged a 25% reversal off the IPO lows and may offer a nice opportunity in the coming days
as its rise may attract some more attention.
Major targets are=
1) $59.00 & $63.99 Fibonacci retracement level.
Crossing the POC (redline) @ $57.52 would be bullish.
$CVAC Curevac Inv Reversal trade
European Covid play, , suffered huge selloff , but seems to have found support.
Potential long entry on break above the 20ma
Ask yourself, why are you taking this trade ?Often, we take up a trade without spending even 1 minute of our time asking the reasons why. I am guilty of that and have paid my tuition fees back to the market.
So, Curevac is backed by Bill Gates of Microsoft and traders start to get imaginative and think the share price is going to rocket up.
Maybe, it will but it is also highly speculative. And is this part of your trade plan or just because it was ranked the top 3 in the forum or on social media, you without batting an eyelid went long.
No, I have no idea if it will go up another 100 or 1000% (I wish I know for sure)but I do not trade IPO stocks as some of you might know. There is just not enough data to plot my chart on.
I am reminded of stocks like this so , to play safe, I would avoid such stocks until later.
A safer bet would be stock like this .
Trade safely.....
CVAC Technnical/Price action AnalysisPaper in the range. The position is accumulating or there are no strong buyers or sellers yet, this can be seen on the Hourly chart. Waiting for the end of consolidation or trading on the trend from the resistance. The short trend from resistance is a more appropriate strategy here in my opinion.
My analysis/assumption for that stock.
Please give your rating if you think this move makes sense.
$CVAC Curevac Bullish Targets
The $300 Million grant from the EU may have not
resulted in the rally that was expected on Friday.
Potential short term targets as per Horizontal resistance levels
& Fibonacci levels $70 is a key level for Bulls to reclaim.
PLEASE GIVE US A LIKE IF YOU FIND OUR CONTENT HELPFUL, THANK YOU.
CVAC Curevac found the bottom on 0.382 fib levelAfter a huge runup CVAC found a bottom on 0.382 level but made a lower high bouncing around 0.786 fib level and 0.382 fib level making a double bot on that 0.382 fib level. The momentum right now is very bullish and if the previous lower high just above 0.618 fib level is broken it will very likely continue its uptrend after retesting that lower high and breaking the $82.69 price target into another highs retest into 1.272 fib level ($95.43 price target) after which it will pullback again. If the prior lower high is not broken that was around $66 price target then it will very likely go down further to 0.236 fib level($46 price target) or consolidate even more and creating a triangle formation. If it creates a triangle formation then any news catalyst will very likely break out to the top even up to 1.618($111.64 target).
CVAC Expected to Receive up to 252 million EurosCureVac Expected to Receive up to 252 million Euros from the German Federal Ministry of Research for Further COVID-19 Vaccine Development and Production Capacity Expansion
In July 2020, CureVac had applied to a grant as part of a special program to accelerate the research and development of urgently needed vaccines against SARS-CoV-2. On July 29, the Federal Minister of Education and Research, Anja Karliczek, announced that CureVac and other companies were eligible for funding according to the recommendation of a panel of experts.
Payments are contingent on reaching predefined milestones. CureVac expects funding of up to 103 million euros in 2020 and up to 149 million euros in 2021.
finance.yahoo.com
